LabPozzi's profile picture. Associate Professor St. Louis University School of Medicine researching #antiphospholipid Syndrome, mechanisms of blood clotting, next-gen #antithrombotics

Nicola Pozzi

@LabPozzi

Associate Professor St. Louis University School of Medicine researching #antiphospholipid Syndrome, mechanisms of blood clotting, next-gen #antithrombotics

Pinned

This is cool ! We made the cover of @BloodJournal !! 🎉 Great work by first author @DrKumar_Suresh and collaborators @vittorio_pengo, Flaumenhaft @HemeThrombBIDMC, and @wuccilab. Thanks to @SLUbiochem for support. I am pleased to see this idea becoming reality. Keep believing.

LabPozzi's tweet image. This is cool ! We made the cover of @BloodJournal !! 🎉 Great work by first author @DrKumar_Suresh and collaborators @vittorio_pengo, Flaumenhaft @HemeThrombBIDMC,  and @wuccilab. Thanks to @SLUbiochem for support. I am pleased to see this idea becoming reality.  Keep believing.

Nicola Pozzi reposted

Novel insights into #APS extend beyond #Thrombosis to NETosis, #ComplementActivation and #MicrobiomeDysbiosis. The 2023 ACR/EULAR criteria refine diagnosis. Adjunctive therapies such as HCQ, rituximab and eculizumab show therapeutic potential: pmc.ncbi.nlm.nih.gov/articles/PMC12… #MedTwitter

APSsupportUK's tweet image. Novel insights into #APS extend beyond #Thrombosis to NETosis, #ComplementActivation and #MicrobiomeDysbiosis. The 2023 ACR/EULAR criteria refine diagnosis. Adjunctive therapies such as HCQ, rituximab and eculizumab show therapeutic potential: pmc.ncbi.nlm.nih.gov/articles/PMC12… #MedTwitter

Nicola Pozzi reposted

🏅Celebrating 50 Years of Service: Honoring Dr. Terry Moore’s Legacy in #Rheumatology | @SSMHealthSTL #InternalMedicine 🩺🏥 🫶🏼The IM Department is privileged to celebrate Dr. Moore’s remarkable 50 years of dedication and leadership in building the legacy of our Rheumatology…

KristaLentine's tweet image. 🏅Celebrating 50 Years of Service: Honoring Dr. Terry Moore’s Legacy in #Rheumatology | 
@SSMHealthSTL  #InternalMedicine 🩺🏥
 
 🫶🏼The IM Department is privileged to celebrate Dr. Moore’s remarkable 50 years of dedication and leadership in building the legacy of our Rheumatology…

Nicola Pozzi reposted

New insights to consider in the clinical approach to #TMA: rpthjournal.org/article/S2475-… On the lack of response to #complement blockade therapy and high rates of recurrence among patients with #plasminogen variants. #anticoagulation #cmTMA @anuja_java


Nicola Pozzi reposted

GRASP: a model for protein complex structure prediction that integrates data from crosslinking, covalent labeling, chemical shift perturbation, and deep mutational scanning experiments. @PKU_CCME @Turnstiles14 nature.com/articles/s4159…

naturemethods's tweet image. GRASP: a model for protein complex structure prediction that integrates data from crosslinking, covalent labeling, chemical shift perturbation, and deep mutational scanning experiments. @PKU_CCME @Turnstiles14 

nature.com/articles/s4159…

Nicola Pozzi reposted

Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.

APS_ACTION's tweet image. Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.
APS_ACTION's tweet image. Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.

Nicola Pozzi reposted

New preprint - basically we noticed that by applying ab initio (SDG) at high res in CS, using a very small step size, we could crack some small proteins we hadn't been able to solve before. Read the preprint or head over to bluesky for a longer thread! biorxiv.org/content/10.110…


Nicola Pozzi reposted

Is someone you love at risk for an aortic aneurysm? This Aortic Disease Awareness Month, take a moment to learn the risk factors, understand who should be screened, and find out how testing can help save lives: bidmc.org/aorticscreening


Nicola Pozzi reposted

Did you know that #Plasminogen activation and plasmin activity are not necessary to #prevent venous thrombosis/thromboembolism ashpublications.org/blood/article/…


Nicola Pozzi reposted

Latest publication in @jlipidres “The Risk of Going Outside: Amino Phospholipids in Rheumatoid Arthritis” by @LabPozzi et al. jlr.org/article/S0022-… @ASBMB

LetPub's tweet image. Latest publication in @jlipidres “The Risk of Going Outside: Amino Phospholipids in Rheumatoid Arthritis” by @LabPozzi et al. jlr.org/article/S0022-… @ASBMB

Nicola Pozzi reposted

🧬 New in @RPTHjournal. Led by @ShreyaAgarwalMD We share a case series of #TMA pts with Plasminogen mutations ✅Variable response to complement blockade ✅Structural mapping by @LabPozzi provides insights into potential mechanisms!! rpthjournal.org/article/S2475-…

anuja_java's tweet image. 🧬 New in @RPTHjournal. Led by @ShreyaAgarwalMD 
We share a case series of #TMA pts with Plasminogen mutations 

✅Variable response to complement blockade
✅Structural mapping by @LabPozzi provides insights into potential mechanisms!!

rpthjournal.org/article/S2475-…

Nicola Pozzi reposted

The 3-decade-old competition that enabled the emergence and evaluate of AlphaFold has run out of NIH funding. The program will be terminated in weeks. This is terminating success. science.org/content/articl…

slavov_n's tweet image. The 3-decade-old competition that enabled the emergence and evaluate of AlphaFold has run out of NIH funding.

The program will be terminated in weeks.

This is terminating success.

science.org/content/articl…

Nicola Pozzi reposted

ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards


Nicola Pozzi reposted

Patients with cancer are at high risk of clinically relevant bleeding, regardless of anticoagulation use. ow.ly/upqz50UgFrV #thrombosisandhemostasis #clinicaltrialsandobservations

BloodPortfolio's tweet image. Patients with cancer are at high risk of clinically relevant bleeding, regardless of anticoagulation use. ow.ly/upqz50UgFrV #thrombosisandhemostasis #clinicaltrialsandobservations

Nicola Pozzi reposted

I have had the honor of serving on the @HTRStoday 2025 Scientific Symposium planning committee over the last year. There is going to be a great program. We have a record number of abstracts submitted. Make plans now to attend in March 2025!!

ericsmullins's tweet image. I have had the honor of serving on the @HTRStoday  2025 Scientific Symposium planning committee over the last year. There is going to be a great program. We have a record number of abstracts submitted. Make plans now to attend in March 2025!!

Life is a melody, with enzymes as instruments and ligands as music directors. We show how two ligands binding to the same pocket of an enzyme can produce different melodies—the magic of allostery! Great job, Ponzar, Chinnaraj et al. @SLUbiochem, @HemeThrombBIDMC, and @UniPadova

Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of…

JTHjournal's tweet image. Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. 

This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of…


Nicola Pozzi reposted

Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of…

JTHjournal's tweet image. Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. 

This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of…

Nicola Pozzi reposted

Free scientific illustrations for biologists! 😍 @NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations! all freely available in the public domain. Retweet and spread the message! bioart.niaid.nih.gov

rafeequemavoor's tweet image. Free scientific illustrations for biologists! 😍

@NIH has released a library of 500+ free scientific illustrations  to create figures, presentations, and illustrations!   

all freely available in the public domain. 

Retweet and spread the message!
bioart.niaid.nih.gov

Nicola Pozzi reposted

T-48 hrs until the start of our 3rd Annual @WashUHeme Retreat! Excited to hear about the latest research from our trainees & faculty, and especially thrilled to welcome @aswolberg for the Evan Sadler Special Lectureship! #hematology @WashUDeptMed

mpndoc's tweet image. T-48 hrs until the start of our 3rd Annual @WashUHeme Retreat! Excited to hear about the latest research from our trainees & faculty, and especially thrilled to welcome @aswolberg for the Evan Sadler Special Lectureship! #hematology @WashUDeptMed
mpndoc's tweet image. T-48 hrs until the start of our 3rd Annual @WashUHeme Retreat! Excited to hear about the latest research from our trainees & faculty, and especially thrilled to welcome @aswolberg for the Evan Sadler Special Lectureship! #hematology @WashUDeptMed

🧐...By demonstrating distinct functional profiles of Type-I and Type-II anti-prothrombin autoantibodies in human plasma, we introduce a new concept: the Antiphospholipid Syndrome Autoantibody Atlas (APSAA)...💡🤯... Check it out... doi.org/10.1016/j.jtha…


Nicola Pozzi reposted

Does inflammation interfere with lupus anticoagulant testing in the Russel Vioer venom assay? 🐍 Read this article from Michael Hardy and team to find out : rpthjournal.org/article/S2475-…

RPTHjournal's tweet image. Does inflammation interfere with lupus anticoagulant testing in the Russel Vioer venom assay? 🐍

Read this article from Michael Hardy and team to find out : 

rpthjournal.org/article/S2475-…

United States Trends

Loading...

Something went wrong.


Something went wrong.